Stephen Feider
CFO at Beta Bionics, Inc. (BBNX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | BBNXBeta Bionics, Inc. | Sell | 6,675159,378 held (−4%) | $19.11 | $128K | -7.7% |
| Jul 2SEC | BBNXBeta Bionics, Inc. | Sell Plan | 5,104166,053 held (−3%) | $17.05 | $87K | +3.4% |
| Jul 2SEC | BBNXBeta Bionics, Inc. | Sell Plan | 4,896166,053 held (−3%) | $17.03 | $83K | +3.5% |
| Jun 30SEC | BBNXBeta Bionics, Inc. | Sell Plan | 5,104165,931 held (−3%) | $17.05 | $87K | +3.4% |
| Jun 30SEC | BBNXBeta Bionics, Inc. | Sell Plan | 4,896165,931 held (−3%) | $17.03 | $83K | +3.5% |
| Jun 3SEC | BBNXBeta Bionics, Inc. | Sell | 6,676166,053 held (−4%) | $12.61 | $84K | +39.8% |
| Mar 3SEC | BBNXBeta Bionics, Inc. | Sell | 1,428172,729 held (−1%) | $12.36 | $18K | +42.6% |
| Jan 5SEC | BBNXBeta Bionics, Inc. | Sell Plan | 20,00042,614 held (−32%) | $29.53 | $591K | -40.3% |
| Dec 4SEC | BBNXBeta Bionics, Inc. | Sell | 1,42742,614 held (−3%) | $29.34 | $42K | -39.9% |
| Oct 7SEC | BBNXBeta Bionics, Inc. | Sell Plan | 3,82845,195 held (−8%) | $21.52 | $82K | -18.1% |
| Oct 7SEC | BBNXBeta Bionics, Inc. | Sell Plan | 1,15444,041 held (−3%) | $22.28 | $26K | -20.9% |
| Oct 3SEC | BBNXBeta Bionics, Inc. | Sell Plan | 14,91844,141 held (−25%) | $20.76 | $310K | -15.1% |
| Oct 3SEC | BBNXBeta Bionics, Inc. | Sell Plan | 10044,041 held (−0%) | $21.08 | $2K | -16.4% |
- Sell
CFO Stephen Feider sold $87K of BBNX at $17.05 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Stephen Feider sold $83K of BBNX at $17.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Stephen Feider sold $87K of BBNX at $17.05 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Stephen Feider sold $83K of BBNX at $17.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Stephen Feider sold $591K of BBNX at $29.53 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Stephen Feider sold $82K of BBNX at $21.52 — pre-scheduled 10b5-1 plan sale.